Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial Enriqueta Felip , Nasser K. Altorki , Caicun Zhou +18 more 2021 The Lancet 1356 citations